Clinical trial · Observational
Evaluation of Lung Metastases Based on Ultrashort Echo Time MRI
The Diagnostic Value of Lung Ultrashort Echo Time MRI for Potential Lung Metastases in Children With Hepatoblastoma
NCT05763173CI-TRIAL-00076217completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Analyze the diagnostic efficiency (including performance, diameter, and location of nodules) of UTE-MRI in lung metastases of hepatoblastoma with chest CT as gold standard
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hepatoblastoma | Hepatoblastoma | ONTOLOGY_EXACT | 0.98 |
| Radiology | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- UTE-MRI assessment of lung metastases with chest CT as gold standard
- timeFrame
- Baseline to 14 days
- description
- Analyze the diagnostic efficiency (including performance, diameter, and location of nodules) of UTE-MRI in lung metastases of hepatoblastoma.
Eligibility
Eligibility (as posted)
- Sex
- All
- Maximum age
- 14 Years
Show eligibility criteria text
Inclusion Criteria: * Children diagnosed as hepatoblastoma (including treated with neoadjuvant chemotherapy but not surgery) * Recent chest CT scan (within 14 days) * No MRI contraindications * The guardian of the children are willing to undergo the examination after full communication and informed consent Exclusion Criteria: * MRI contraindications (including but not limited to: contrast medium allergy; Claustrophobia;Metal implants;chronic kidney disease≥stage 3 (glomerular filtration rate \< 60 mL min-1 (1.73 m2)-1)) * Patients with hepatoblastoma aged 14 years and above * Children after surgery for hepatoblastoma * Application of any contrast medium within 24 h before the MRI and/or CT examinations * There is a concomitant medical condition (e.g. poorly controlled hypertension, severe diabetes, neurological or psychiatric illness, etc.) or any other condition that would seriously endangers the subject's safety, may confuse the study results, or may interfere with the subject's completion of the study according to the investigator's judgment.
References
Publications (0)
Data not yet available
No reference posted for this study.